Psoriasis : : new research / / edited by Shahin Aghaei.
Psoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some c...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London : : IntechOpen,, 2022. ©2022 |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (xii, 198 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993603626204498 |
---|---|
ctrlnum |
(CKB)5580000000514304 (NjHacI)995580000000514304 (EXLCZ)995580000000514304 |
collection |
bib_alma |
record_format |
marc |
spelling |
Psoriasis : new research / edited by Shahin Aghaei. London : IntechOpen, 2022. ©2022 1 online resource (xii, 198 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Psoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some cases, it may involve larger parts of the skin, as well as nails and joints in some cases. This book presents a comprehensive overview of psoriasis, including clinical aspects, differential diagnosis by dermoscopic devices, comorbidities, immune system changes, methotrexate therapy, and topical innovative molecular targeted therapeutics. 1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis. Dermatology. Psoriasis. 1-80355-377-4 Aghaei, Shahin, editor. |
language |
English |
format |
eBook |
author2 |
Aghaei, Shahin, |
author_facet |
Aghaei, Shahin, |
author2_variant |
s a sa |
author2_role |
TeilnehmendeR |
title |
Psoriasis : new research / |
spellingShingle |
Psoriasis : new research / 1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis. |
title_sub |
new research / |
title_full |
Psoriasis : new research / edited by Shahin Aghaei. |
title_fullStr |
Psoriasis : new research / edited by Shahin Aghaei. |
title_full_unstemmed |
Psoriasis : new research / edited by Shahin Aghaei. |
title_auth |
Psoriasis : new research / |
title_new |
Psoriasis : |
title_sort |
psoriasis : new research / |
publisher |
IntechOpen, |
publishDate |
2022 |
physical |
1 online resource (xii, 198 pages) : illustrations |
contents |
1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis. |
isbn |
1-80355-377-4 |
callnumber-first |
R - Medicine |
callnumber-subject |
RL - Dermatology |
callnumber-label |
RL321 |
callnumber-sort |
RL 3321 P767 42022 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.526 |
dewey-sort |
3616.526 |
dewey-raw |
616.526 |
dewey-search |
616.526 |
work_keys_str_mv |
AT aghaeishahin psoriasisnewresearch |
status_str |
n |
ids_txt_mv |
(CKB)5580000000514304 (NjHacI)995580000000514304 (EXLCZ)995580000000514304 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Psoriasis : new research / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653242650722304 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02114nam a2200313 i 4500</leader><controlfield tag="001">993603626204498</controlfield><controlfield tag="005">20230702034823.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230702s2022 enka o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5580000000514304</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995580000000514304</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995580000000514304</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RL321</subfield><subfield code="b">.P767 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.526</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Psoriasis :</subfield><subfield code="b">new research /</subfield><subfield code="c">edited by Shahin Aghaei.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 198 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Psoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some cases, it may involve larger parts of the skin, as well as nails and joints in some cases. This book presents a comprehensive overview of psoriasis, including clinical aspects, differential diagnosis by dermoscopic devices, comorbidities, immune system changes, methotrexate therapy, and topical innovative molecular targeted therapeutics.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Dermatology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Psoriasis.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-80355-377-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aghaei, Shahin,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:13:33 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-02-11 21:29:23 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5343023870004498&Force_direct=true</subfield><subfield code="Z">5343023870004498</subfield><subfield code="b">Available</subfield><subfield code="8">5343023870004498</subfield></datafield></record></collection> |